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ANALYSIS OF DONOR SITE HEALING  FOLLOWING
HARVESTING OF SPLIT SKIN GRAFT
ABSTRACT
AIM :
To Study
1. The problems encountered during the process of donor site healing
following harvesting of split skin grafts
PAIN
AMBULATION
REEPITHELISATION
DONOR SITE INFECTION
2. Comparative study between  Closed  and  Open dressing
(Haemocoagulase + Collagen) for the skin graft donor site and its
influence on the above factors  associated with donor site healing
MATERIALS AND METHODS:
Closed dressing with sterile Vaseline gauze and Open dressing
using Botroclot with sieved moist  collagen were applied to two different
subsets  of   50  donor  sites  following   Split  Skin  Grafts   in  each   group
(TOTAL -100)
INCLUSION CRITERIA:
? All donor sites of  the Split Skin Grafts
? All patients were treated with vitamin and protein supplements and
appropriate antibiotics.
? Blood transfusion to keep Haemoglobin minimum  at  10gm%
EXCLUSION CRITERIAS :
Patients with Diabetes mellitus, Hypoproteinemia, Anemia were
excluded from study.
Large donor site raw areas were excluded from study in both
groups.
FACTORS ANALYSED:
? Pain
? Early Ambulation
? Re epitheliation of  the donor site wounds after 2 weeks
? Cost factor analysis
? Complications
PERIOD OF STUDY- NOVEMBER 2009 TO JANUARY 2012
OBSERVATION & RESULTS
PAIN
 In our study, among the patients  the who had the conventional
donor site dressing with meshed Vaseline gauze had a median pain score
of  5  observed  in  23  patients.  Minimum  pain  score  in  this  group  was  3
noted in 2 patients. Maximum pain score was 6 experienced in 4 patients.
Pain score of 4 was noted in 21 patients.
In comparision the Combination Dressing group with
Haemocoagulase and Collagen Dressing had different results. The
median pain score was 2 experienced in 27 patients. Minimum pain score
was 1 noted in 6 patients. Maximum pain score noted in the collagen
dressing group was 4 observed in 4 patients. The remaining 13 patients
experienced a pain score of 3. Pain was drastically reduced in the
Collagen Dressing patients.
AMBULATION
Since the pain score was high in the closed dressing subset of
patients, it limited their mobilization and 22 patients were ambulant only
on postoperative day 3. Only 10 patients were ambulant on the 2nd post
operative day. The remaining 18 patients ambulated well only on the 4th
postoperative day.
Due to the decreased pain in the collagen dressing for the donor
site  patients  ambulated  early  and  27  patients  were  ambulant  from  1  st
postoperative day.
Subsequently 21 patients were ambulant on 2nd post operative day.
The remaining 2 patients ambulated on the 3rd postoperative day. Early
ambulation was noted in the in patients with the collagen dressing
RE EPITHELISATION
Donor site reepithelisation was assessed in the closed dressing by
the loosening of the dressings average time taken for the donorsites to
reepitheliase  was  20  -23  days.  Due  to  complications  of  donor  site
infection   the  donor  site  healing   extended  to  29  -31  days  in  about  6
patients.
Donor site reepithelisation was noted between 15-17 days in the
collagen dressing group. In 2 patients donor site healing was delayed to
21-23 days due to donor site infection which was treated by conservative
methods due to the ease of inspection of donor site and had the advantage
of early identification of donor site complications. In 1 patient there was
displacement of collagen sheet from the donorsite  and it was converted
to closed dressing and excluded from study. The healing time noted in
that  patient was 23 days.
COST FACTOR ANALYSIS
The cost for the conventional Closed Dressings was Rs .150
inclusive of the  over padding needed in review period. The cost factor
for application 25x40 cm Collagen Sheet to the donor site was Rs.450.
DONOR SITE COMPLICATIONS
Infection
Donor site infection was noted in 6 patients of the Closed  Dressing
group. It was managed with conservative dressings with Framycetin.
Donor site dressings on  periodic review showing excessive soakage with
foul smell were opened end  wound swabs taken
Donor site infection noted in 2 patients in the Collagen Dressing
group, conservative dressings done to treat with the infection in these
patients.
Collagen  Displacement-
1 patient in the study group had shearing of collagen sheet when
applied to donor  site in the postoperative period. Wound was cleaned and
Closed Dressing applied and patient was excluded from the study.
CONCLUSION
Haemocoagulase with Collagen sheet application for donor site
have the following advantages.
? Less pain over the donor site compared to the conventional Closed
Dressing with Vaseline gauze.
? Early ambulation due to reduced pain after the application of
Collagen Sheet to the donor site.
? Reepithelisation complete for most patients and time of
reepithelisation is similar to the standard expensive dressings for
the donor site.
? Inspection  of  the  donor  site  wound  can  be  done  easily  and
complications can be recognized early.
? A Comfortable Dressing due to the decreased bulk of dressing and
ease to wear the garments over the dressing.
? Less complications and better outcome compared to the
conventional closed dressing.
1INTRODUCTION
Skin is the largest organ of the human body, representing
approximately 16% of the total body weight. While the functions of
protection and thermoregulation are well recognized, skin also has
important metabolic functions in protein and vitamin D metabolism. The
human body produces the greatest amount of vitamin D in the epidermal
layer  of  the  skin[17].  In  addition  to  providing  a  physical  barrier  to
pathogenic organisms, skin functions as an active immune organ with
distinctive antigenic properties that play a significant role with particular
regard to composite tissue allo trans plantation.[30]
Restoration of an intact barrier is of critical importance and may be
achieved in numerous ways, including grafting. Among the indications
for skin grafting are promotion of accelerated healing of burns and other
wounds, reduction of insensible fluid loss, and protection from bacterial
invasion, reduction of scar contracture, enhancement of cosmesis,
Skin grafts are used to cover extensive wound areas or wounds
which may result in scarring. Donor site wounds are often more  painful
than the skin graft wound. Skin graft and donor site  wounds should be
cared for by a  knowledgeable practitioner trained in the care and
management of skin graft and donor site wounds. It is of vital importance
that the patient is aware that in order to heal the original wound a second
wound must be created, which will also produce a scar. The patient
2should also be warned that the donor site wound may be more
uncomfortable than the graft site wound due to the exposure of sensory
nerve endings (Weber et al, 1995).
Inspite of newer advances split thickness skin grafts(STSG) still
have an important place in many areas of plastic surgery. Though the
technique of skin grafting is more or less standardized the treatment of
the donor site  differs  greatly and has been a topic of  debate.  The STSG
donor site usually receives little attention and is often a source of delayed
healing with considerable pain and discomfort to the patient. Thus it is
not uncommon for patients to complain more about the pain at the donor
site than at the site of surgery.
Skin is natural barrier that prevents penetration of pathogens and
escape of interstitial fluid. The harvest of a split thickness skin graft
causes a partial thickness injury and an outflow of blood and protein rich
exudate from the wound. This exudate and coagulated blood combine to
form an eschar which provides a temporary cover to the wound and
underlying regenerating epithelium. However the eschar does not prevent
tissue desiccation and infection at the donor site which can thus convert a
partial thickness injury to a full thickness loss. After the harvest of STSG,
the new epidermis arises from proliferation of the remaining epithelial
cell layer at the donor site periphery and reserve cells in the remaining
hair follicles, sebaceous glands and sweat glands. This is the first phase in
3the healing of a donor site. The process of cell proliferation is followed
by migration of the cells outward until the wound is reepithelialised.2
Complete re-epithelialisation occurs in 10-14 days, although the rate may
be affected by the thickness of graft taken.  (23)
Healing of donor site wounds occurs through reepithelialisation.
Epithelial cells migrate from the remnants of hair follicles, sebaceous and
sweat glands remaining  in the reticular dermis of the skin and spread
across the wound bed until full skin integrity is restored. This usually
occurs within 7–10 days, but may take as long as 21 days, depending on
the age and nutritional status of the patient. Wound healing in the elderly
may be speedier if the surgeon uses a small amount of the skin graft and
widely  fenestrates  it  to  apply  as  a  dressing  to  the  donor  site  (Fatah  and
Ward,1984). The dual action of the skin graft spreading across the
wound, together with re-epithelialisation from the remains of hair
follicles, sweat and sebaceous glands would speed healing. In the ?rst 3–
4 days post surgery, the donor site wound produces moderate to heavy
amounts of exudate, depending on the size of the wound area. After this,
exudate levels diminish as re-epithelialisation progresses.
To minimise discomfort for the patient it is vital to use an
appropriate dressing. Removal of an inappropriate dressing can cause a
great deal of pain and may even delay wound healing (European Wound
Management Association[EWMA], 2002). One dressing which could be
4applied to the donor site and left in situ until the wound is healed would
be ideal. However, this is unlikely due to the variability of patient, skin
texture, wound site, etc.  The goal of treating skin graft donor sites is to
promote healing while minimizing the risk of introducing new
complications and pain to an already traumatized patient.  Moist wound
healing is not a new idea and providers continue to strive to find the
optimal treatment that provides this ideal, moist environment.
Collagen dressings used are composed of type 1 and type 3 bovine
collagen which is similar to human collagen and thus prevents rejection.
It is commercially available in a sterile pack and is thus easy to use.
Collagen as a donor site dressing has shown that the time to
complete reepithelialisation is comparable with other dressing materials
(28). However it is not possible to assess the true wound healing as the
wound cannot be kept under continuous observation and the mean time to
the first dressing may be longer. Thus many of the donor sites may have
healed long before they are first inspected.
Patients with collagen dressings are found to have only minimal to
moderate pain in the entire post operative period and during the first
dressing. In these patients analgesic requirement is reduced and early
mobilisation can be done. Thus the major advantage of using collagen as
a donor site dressing is decreased pain. The collagen sheet once adherent
5to the wound has low friction between the wound surface and dressing
and this has made it suitable for awkwardly sited donor sites. Also once
applied it does not require a bulky dressing which would hamper
mobilisation, or require a change of dressing as there is no soakage of the
dressing due to wound exudate.
The collagen provides a scaffolding for epithelial regrowth and
prevents exudation from the raw area. (14,72) After 48 hours the film is
transformed into a stiff sheet which is stable enough to withstand pressure
and shearing of clothes. Thus it protects the donor site from mechanical
trauma and infection and decreased loss of protein  in exudate. When
reepithelialisation is completed the overlying film and coagulated blood
separates spontaneously. Thus removal of the dressing is easy and pain
free.
Disadvantages seen with the use of a collagen dressing is the
formation of an haematoma in cases where meticulous haemostasis has
not been achieved. Also infection at the donor site causes a complete
degradation of the film and is associated with significant donor site pain.
Thus donor site pain in patients where collagen dressing is used is highly
suggestive of wound infection. (26,27) The wound infection is usually
limited to the donor area with no associated systemic infection, and it
6does  not  convert  the  donor  site  to  a  full  thickness  loss  and  once  the
wound is redressed it does not affect the time of reepithelialisation.
Thus collagen dressings appear to have a great advantage over
other dressing materials for donor sites especially in terms of a pain free
donor site and thus early mobilisation of the patient and a decreased
morbidity. With its ease of application, with no need for redressing, a
pain free donor site reepithelialisation in the  accepted time it attempts to
fulfil the criteria of an ideal donor site dressing.
7AIM OF THE STUDY
AIM
To Study
1. The problems encountered during the process of donor site healing
following harvesting of split skin grafts
PAIN
AMBULATION
REEPITHELISATION
DONOR SITE INFECTION
2. Comparative study between  Closed  and  Open dressing
(Haemocoagulase + collagen) for the skin graft donor site and its
influence on the above factors  associated with donor site healing.
8REVIEW OF LITERATURE
HISTORY
The history of skin grafts has its beginnings in ancient India, where
Sanskrit texts document skin transplants performed by Hindus in 3000-
2500 BC. Potters and tilemakers of the Koomas caste were reconstructing
noses which had been mutilated as punishment for crimes such as theft
and adultery. Grafts were obtained from buttock skin, which was
reportedly slapped with a wooden paddle until red and congested, and
then cut with a leaf to the appropriate size .
Despite early attempts at plastic and reconstructive surgery,
hundreds of years passed until further work advanced the practice of skin
transplantation. In Italy in1442 AD, Brancas developed a novel technique
of binding the patient's arm to the site of the skin graft . Brancas used skin
from  the  arm  to  transplant  a  slave's  nose  to  his  master's  nose.  He
unfortunately did not receive recognition for his technique of nasal
reconstruction, which was instead credited to his fellow countryman,
Tagliacozzi, over a hundred years later. Tagliacozzi, who is considered to
be the pioneer of modern plastic surgery, publicized Brancas' method of
skin grafting. Although he repaired soldiers' facial battle wounds, the
most common reason for nose deformities at that time was tissue
infection due to syphilis. In 1597, Tagliacozzi published his work in "De
9curtorum chirurgia per insitionem," and in so doing, transformed plastic
surgery from a trade service to a scientific procedure .
Prior to the 1800's, reports (if skin grafting were mostly anecdotal.
In 1663, the Royal Society of London attempted experimental skin grafts
using a dog . After a few failed attempts at securing the graft, followed by
the escape of their canine subject, research in that area was temporarily
abandoned. In 1731, Garengeot was ridiculed when he reported his
experience of warming in wine and then reattaching a soldier's partially
amputated nose . Although the Italians had  been performing skin
transplantation for quite some time, news of India's  longstanding method
of skin grafting was only first reported in Europe in 1794 .
The nineteenth century would prove to be the most influential
period with regard to the advancement and acceptance of skin grafting.In
1804 Baronio demonstrated the first successful autograft using the backs
of  sheep . By 1823, Bunger achieved the same success with autografts in
human subjects. Attempting to revive the ancient Indian method of
rhinoplasty, Bunger  repaired nasal defects using full-thickness skin grafts
from the patient's thigh .
 In 1869, the Swiss surgeon Reverdin performed the first allograft
by pinch grafting very thin pieces of epidermis ('epidermic grafts') .
Using this firstsplit-thickness skin graft, Reverdin demonstrated a more
rapid healing of granulating wounds. Two years later, Oilier furthered
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Reverdin's work and demonstrated a better outcome by using skin grafts
that were not only composed of epidermis, but also contained a portion of
the dermis . These dermoepidermic' grafts effected faster wound healing
with less scarring. In 1871 Pollock introduced the idea of using skin
grafts  to  treat  burn  wounds  .  He   donated  small  pieces  of  his  own  skin
which he used in conjunction with a burn victim's skin to cover a large
denuded area. The idea was brilliant and paved the way for one of the
most important modern functions of skin grafts, the treatment of burn
victims. By the end of the century, Wolfe  had introduced full- thickness
skin grafts into clinical practice to treat ectropion, and Girdner (14) had
published the first report of skin grafting with human cadaveric skin.
The use of skin grafts revolutionized the care and ultimately the
mortality of burn patients. The evolution of the practice of skin grafting
in the twentieth century has concurrently advanced our understanding of
the biology of wound healing and the  immunology of transplant
rejection. Skin grafting continues to be a science in progress.
George Winter is often referenced as a pioneer among wound-care
practitioners because of his work in the early 1960s that proved wounds
re-epithelialize quicker in a moist environment (Winter, 1963). It is
indeed the epithelialization process on which we focus when treating the
skin graft donor site.An old and still  practiced strategy is to cover the
wound with  petrolatum (paraffin) gauze and allow it to dryout. Drying
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was often  accomplished with the use of hair dryers, heating  blankets
(bear huggers), or air drying. The procedure often  resulted in  pain and
discomfort   for  the  patient,  and  vigilance   was  needed  to  regularly  trim
the  edges of the dressing as it  peeled away from the healing wound. If
not done, the dressing could catch on clothing or linen, causing pain to
the patient,  trauma to  thewound, and necessitating a repeat of the drying
process.   Essentially,  the  wound  was  left  open  to  scab,  which  is
contradictory to the best evidence-based  practice of today,  that of moist
wound healing.
In recent years, much has been published highlighting the benefits
of moisture-retentive  dressings in treating donor sites. Moisture-retentive
dressings that have been used include  hydrocolloids, foams, and
transparent thin film dressings, alone or in combination  with absorbent
materials such as alginates, hydrofibers or gauze. While hydrocolloids
and foams provide the needed  absorbency, they must be removed
whenever wound  inspection is required, increasing treatment cost and the
risk of traumatizing the wound. Thin film dressings allow for  wound
visualization, but usually fail to contain the drainage  for more than 24
hours, even when used secondary to other  absorbent dressings(which
also  negates  the  benefit  of   transparency).  The   importance   of   rapid
healing  in  skin  graft   donor  sites   is  emphasized  by  the  increasing
number  of  methods  designed  to  achieve  earlierreepithelialization
[17];  however,  other  unique  concerns  are  associated  with  the  skin
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graft  donor  site.  In  large  burns,  improved  healing  may  allow  for
faster  reharvesting,  whereas  in  smaller  injuries,  hastened
epithelialization  may  result  in less  scarring.
Conversely,  a  secondary  infection  may  either  slow  the healing
process  or   ultiimately  convert  a  partial  skin-thickness  donor  site  to
a   full  skin-thickness  loss  . [70,30].  Thus,  size  of  the  donor  site,
site   selection,   skin  preparation,   graft   depth,   hemostasis    (23),  [57],
and   choice   of   dressing   become    important   considerations.   All   of
these  issues  have  a role  in  the  ultimate  healing  of  a skin graft  donor
site  and  in  the  incidence  of infection.
Accelerated healing at skin graft donor sites has enormous
advantages to patient health. When large burn injuries decrease the
availability of viable donor sites, one option available to surgeons is
subsequent reuse of a donor site  after it has completely re-epithelialized.
However, producing a viable split thickness skin graft from a previously
harvested donor site can take as long as 3 weeks.[70].
Once a graft is harvested the dermis lost at donor site is not
replaced. Only  reepithelisation occurs and epidermis is formed. The
dermis harvested is a net loss  at the donor site. Repeated harvesting at
same donor site cause progressive thinning of dermis at donor
site.Subsequent layers of graft are less elastic. An ideal  dressing method
prevents dehydration and infection  while facilitating wound  healing.
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Conventional donor-site dressings consist of vaseline gauze and
gauze dressings. While many plastic-surgery units have moved away
from  these,  other   disciplines  use  skin  grafts  and  still  use  this  type  of
dressing. Vaseline gauze  dressings have many disadvantages as they are
permeable to bacteria when wet.
They  also  allow  the  donor  site  to  dry  out  and  –  as  well  as  being
prone to slipping,  exposing nerve endings – they adhere to those nerve
endings. Other disadvantages  include their bulk and the fact that the
patient cannot bathe.
Biological dressings like collagen are impermeable to bacteria, and
create the most  physiological interface between the wound surface and
the environment. Collagen dressings have other advantages over
conventional dressings in terms of ease of  application and being natural,
non-immunogenic, non-pyrogenic, hypo-allergenic,  and pain-free.
ANATOMY
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The  skin  consists  of  2  layers  .  The  outer  layer,  or  epidermis,  is
derived from  ectoderm, and the thicker inner layer, or dermis, is derived
from mesoderm. The  epidermis constitutes about 5% of the skin, and the
remaining 95% is dermis.
The skin varies in thickness depending on anatomic location,
gender, and age of  the individual. Skin is thickest on the palms and soles
of  the  feet,  while  the  thinnest   skin  is  found  on  the  eyelids  and  in  the
postauricular region. Male skin is  characteristically thicker than female
skin in all anatomic locations. Children have  relatively thin skin, but
around age 11 years, the skin progressively thickens. This  thickening
continues until the fourth or fifth decade of life, when the skin begins to
thin, primarily due to loss of dermal elastic fibers, epithelial appendages,
and  ground substance.
EPIDERMIS
The epidermis, the more external of the two layers, is a stratified
squamous epithelium consisting primarily of keratinocytes in progressive
stages of differentiation from deeper to more superficial layers. The
epidermis has no blood vessels; thus, it must receive nutrients by
diffusion from the underlying dermis  through the basement membrane,
which separates the 2 layers.
15
DERMIS
The dermis is a more complex structure. It is composed of 2 layers,
the more  superficial papillary dermis and the deeper reticular dermis.
The papillary dermis is  thinner, consisting of loose connective tissue that
contains capillaries, elastic  fibers, reticular fibers, and some collagen.
The reticular dermis consists of a thicker  layer of dense connective tissue
containing larger blood vessels, closely interlaced  elastic fibers, and
coarse, branching collagen fibers arranged in layers parallel to  the
surface. The reticular layer also contains fibroblasts, mast cells, nerve
endings,  lymphatics, and some epidermal appendages. Surrounding the
components of the  dermis is the gel-like ground substance composed of
mucopolysaccharides  (primarily hyaluronic acid), chondroitin sulfates,
and glycoproteins.
EPITHELIAL CELL SOURCES
Epidermal appendages are important sources of epithelial cells that
re-epithelialize  when the overlying epithelium is removed or destroyed in
patients with partial  thickness burns, abrasions, or split-thickness skin
graft harvesting. These intradermal epithelial structures, such as
sebaceous glands, sweat glands, and hair  follicles, are lined with
epithelial cells with the potential for division and  differentiation. They
are found deep within the dermis and in the subcutaneous fat  deep to the
dermis.
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SEBACEOUS GLANDS
Sebaceous glands, or holocrine glands, secrete sebum, which
serves to lubricate the  skin and make it more impervious to moisture.
They are found over the entire  surface of the body except the palms,
soles, and dorsum of the feet. They are  largest and most concentrated in
the face and scalp where they are the site of origin  of acne.
SWEAT GLANDS
Sweat glands, or eccrine glands, are found over the entire surface
of the body  except the lips, external ear canal, and labia minora. They are
most concentrated in  the palms and soles of the feet. The normal function
of the glands is to produce  sweat, which cools the body by evaporation.
APOCRINE GLANDS
Apocrine glands are similar in structure but not identical to the
eccrine sweat  glands. They are concentrated in the axillae and anogenital
regions. They probably serve a vestigial sexual function because they
produce odor and do not function  prior to puberty.
HAIR FOLLICLES
The hair follicle is another important source of epithelial cells, and
many of the  other epidermal appendages actually open into the hair
follicle rather than directly  onto the skin surface
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PHYSIOLOGY OF SKIN
Functions of the skin include.
1. Protection
2. Homeostasis
3. Excretion
4. Temperature regulation
5. Vitamin D production
6. Sensory perception
7. Psychosocial function, and
8. Wound healing.
SKIN GRAFTS
Thought to have originated in India more than 2,500 years ago,
skin grafting is  the next step on the reconstructive ladder for the closure
of a wound that cannot be  closed primarily.
Skin transplanted from one location to another on the same
individual is termed an  autogenous graft or autograft. Skin grafts are
classified as either split-thickness or full-thickness, depending on the
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amount of dermis included in the graft. A partial  or split-thickness skin
graft  (STSG)  contains  a  variable  thickness  of  dermis,  while   a  full-
thickness skin graft (FTSG) contains the entire dermis. Split-thickness
skin  grafts are further categorized as thin (0.005-0.012 in), intermediate
(0.012-0.018  in), or thick (0.018-0.030 in) based on the thickness of graft
harvested.
The thicker the dermal component, the more the characteristics of
normal skin are maintained following grafting. This is because of the
greater collagen content and the larger number of dermal vascular
plexuses and epithelial appendages contained within thicker grafts.
However, thicker grafts require more favorable  conditions for survival
because of the greater amount of tissue requiring  revascularization. The
choice between full- and split-thickness skin grafting  depends on wound
condition, location, and size, as well as aesthetic considerations.
FULL-THICKNESS SKIN GRAFTS
Full-thickness skin grafts are ideal for visible areas of the face that
are inaccessible  to local flaps or when local flaps are not indicated. Full-
thickness grafts retain  more of the characteristics of normal skin,
including color, texture, and thickness, when compared with split-
thickness grafts. Full-thickness grafts also undergo less  contraction while
healing. This is important on the face as well as on the hands and  over
mobile joint surfaces. Full-thickness grafts in children are more likely to
19
grow with the individual. However, full-thickness skin grafts are limited
to  relatively small, uncontaminated, well-vascularized wounds and thus
do not have  as wide a range of application as split-thickness grafts.
Donor sites must be closed  primarily or, more rarely, resurfaced with a
split-thickness graft from another site.
SPLIT-THICKNESS SKIN GRAFTS
Split-thickness skin grafts can tolerate less ideal conditions for
survival and have a   much broader range of application. They are used to
resurface large wounds, line  cavities, resurface mucosal deficits, close
donor sites of flaps, and resurface  muscle flaps. They also are used to
achieve temporary closure of wounds created  by the removal of lesions
that require pathologic examination prior to definitive  reconstruction.
Split-thickness skin graft donor sites heal spontaneously with cells
supplied by the remaining epidermal appendages, and these donor sites
may be  reharvested once healing is complete.
Split-thickness grafts also have significant disadvantages that must
be considered.
 Split-thickness grafts are more fragile, especially when placed
over areas with  little underlying soft tissue bulk for support, and usually
cannot withstand  subsequent radiation therapy. They contract more
during healing, do not grow with the individual, and tend to be smoother
and shinier than normal skin because of  the absence of skin appendages
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in the graft. They tend to be abnormally pigmented, either pale or white,
or alternatively, hyperpigmented, particularly in darker-skinned
individuals. Their lack of thickness, abnormally smooth texture,  lack of
hair growth, and abnormal pigmentation make these grafts more
functional  than cosmetic. When used to resurface large burns of the face,
split-thickness  grafts may produce an undesirable masklike appearance.
Finally,  the  wound   created  at  the  donor  site  from  which  the  graft  is
harvested is often more painful  than the recipient site to which the graft
is applied.
GRAFT SURVIVAL AND HEALING
The ultimate success of a skin graft, or its "take," depends on
nutrient uptake and  vascular ingrowth from the recipient bed, which
occurs in 3 phases. The first phase  takes place during the first 24-48
hours. The graft is initially bound to the recipient  site through formation
of a fibrin layer and undergoes diffusion of nutrients by capillary action
from the recipient bed by  process called PLASMATIC IMBIBITION.
The second phase involves the process of INOSCULATION, in
which the donor and  recipient end capillaries are aligned and establish a
vascular network.
REVASCULARIZATION of the graft is accomplished through
those capillaries as well as by in growth of new vessels through
neovascularization in the third and final  phase, which is generally
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complete within 4-7 days. Reinnervation of skin grafts  begins
approximately 2-4 weeks after grafting and occurs by ingrowth of nerve
fibers from the recipient bed and surrounding tissue. Sensory return is
greater in  full-thickness grafts because they contain a higher content of
neurilemmal sheaths.
Similarly, hair follicles may be transferred with a full-thickness
graft, which allows the graft to demonstrate the hair growth of the donor
site. Split-thickness grafts are usually hairless.
The amount of dermis present in the graft determines the degree of
contraction  immediately after harvest from the donor site and following
placement and revascularization in the recipient bed. Freshly harvested
grafts undergo immediate recoil as a result of elastin in the dermis in a
phenomenon termed primary contraction. Therefore, a full-thickness skin
graft contracts more initially following harvest as it contains the dermis in
its entirety. Secondary contraction is likely due to myofibroblast activity
in the wound bed  and is defined as the contraction of a healed graft. The
degree of secondary contraction is inversely related to the thickness of
the skin graft.
Accordingly, split-thickness skin grafts contract more than full-
thickness grafts following placement in the recipient bed. For that reason,
full-thickness grafts are preferably used in areas that would be
significantly impacted functionally or aesthetically by scarring or scar
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contracture, such as the head and neck, hands, genitals, or breast. Current
investigations into methods to reduce initial contraction and subsequent
need for contracture release include early mechanical restraint
immediately following grafting as well as application of topical agents to
delay keratinocyte differentiation or prevent crosslink formation. [57]
DONOR SITE SELECTION
Donor site selection is based on multiple factors, including skin
color, texture, dermal thickness, vascularity, and anticipated donor site
.Split-thickness skin grafts are commonly harvested from the thigh,
buttocks, abdominal wall, or scalp.
The method of harvesting the split-thickness skin graft depends
primarily on the size and thickness needed for coverage of the defect.
Smaller grafts can be taken using a "pinch graft" technique using a
scalpel blade; slightly larger freehand grafts can be obtained with a Weck
blade. Powered dermatomes such as the Zimmer (Zimmer, Inc.,) are most
commonly used to harvest split-thickness skin grafts, as they have a
rapidly oscillating blade that can be set at an adjustable depth and width
for appropriate coverage of the defect.
Lidocaine with epinephrine may be injected subcutaneously at the
donor site prior to harvesting, which aids in reducing blood loss and
providing greater tissue turgor to facilitate graft harvest. The planned
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harvest site and dermatome can be lubricated with mineral oil, sterile
saline, or Shur-Clens (ConvaTec, Princeton, NJ) to enable easy gliding of
the dermatome over the skin. Epinephrine-soaked gauze may be applied
to the donor site immediately following harvest to achieve hemostasis.
Hemostasis:
Bleeding from a donor site is similar in amount to that of tangential
excision of a fresh, deep dermal burn, i.e., diffuse, puncture, and profuse.
Bleeding from a reused donor is even more profuse and again an analogy
can be made with a tangential excision of a hyperemic wound. Because
blood loss will be substantial, hemostasis at the donor site should be
controlled before pursuing wound excision.
The  ideal  situation  is  the  use  of  two  teams,  one  whose  role  is  to
obtain skin grafts and maintain hemostasis. Pressure followed by
application of fine mesh gauze or xeroform gauze, again followed by
pressure (1 to 2 minutes) is usually adequate to control bleeding.  As with
the excised wound, topical thrombin or a diluted epinephrine solution can
also be used.
DONOR SITE HEALING:
The split-thickness skin graft donor site epidermis regenerates by
secondary  epithelialization from the wound edges and from immigration
of dermal cells originating in the shafts of hair follicles as well as adnexal
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structures remaining in the dermis. Although the dermis never
regenerates, the same site may be harvested again for subsequent grafts
because only a portion is removed in a split-thickness graft. A skin graft
is typically a thickness of skin comparable in depth to a partial thickness
skin loss, i.e., epidermis and the upper third of the dermis. Typically, the
slice of skin is 0.001 to 0.014 inches thick. A split thickness skin graft
(STSG) of 0.001 inches typically contains the epidermis and upper third
of the dermis, i.e., the papillary dermis. Appendages in the dermis to
allow re- epithelialization in about 14 days. A 0.15 inch thickness graft
usually contains about half of the dermal layer (or more) which includes a
portion of the papillary dermis. Fewer epidermal cells remain and the site
heals much slower, similar to a mid to deep dermal burn.
 Protection of remaining epidermal and dermal elements is
essential to allow for proper healing. The most bioactive portion of the
dermis is removed with a STSG, i.e., the papillary dermis. The donor site
healing will depend on when bioactive dermalgrowth enhancing factors
are produced on the surface which can then stimulate re-epithelialization.
Placement of a tissue engineered wound matrix on the donor site will
provide active extracellular matrix components to stimulate healing.
The usual time for re-epithelialization of a donor site of 0.010 inch,
in depth, is about 14 days in a patient 10 - 50 years old and about 21 days
in a toddler or geriatric patient using a typical grease gauze dressing .The
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donor site is not without impaired cosmesis, however, as(1) hypertrophic
scar formation,(2) Thin Unstable scar or(3) changes in skin pigmentation
can occur upon healing.
In the first 3–4 days postsurgery, the donor site wound produces
moderate to heavyamounts of exudate, depending on the size of the
wound area. After this, exudate levels diminish as re-epithelialisation
progresses.
The healing of donor site wounds can be divided into two phases.
The WET phase is when copious amounts of exudate is produced. An
absorbent dressing such as a foam, alginate or hydro?bre dressing can be
used to absorb the excess.
The DRY phase is when the exudate levels fall dramatically and the
wound bed becomes dry. It can be treated with a simple non-adherent
silicone dressing, which can remain undisturbed without adhering to the
wound bed for several days or until the wound has healed. It is in the
patient’s best interests that one dressing is applied and remains in situ
until healing is achieved. Unfortunately if an alginate or hydro?bre
dressing is  left in situ throughout healing, the dressing is likely to dry out
and possibly adhere  to the wound bed (6).  Foam dressings draw excess
moisture  away   and  have  low  adherence  to  the  wound  bed  so  may  be
appropriate (Wilkinson,1997). Perhaps the most appropriate dressing is a
simple nonadherent silicone dressing (Platt et al, 1996). During the initial
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‘wet phase’ this would need padding and the outer dressing renewed
regularly, otherwise the weight of the  dressing could cause slippage,
resulting in exposure of the wound and distress to  the patient.
COMPLICATIONS:
A number of complications can occur in the donor site. Infection
can occur which can result in deepening and possibly conversion of the
wound to full thickness loss and ulceration.
Infection is usually evident from surrounding cellulitis. Systematic
antibiotics as well as topical antibiotics are required for treatment.
Blistering and continued breakdown are also seen, especially with deep
donors or donors in small children or the elderly. Healing usually occurs
in time. Hyper or hypo-pigmentation may persist for long periods of time
and may be permanent. Hypertrophic scarring is seen especially in dark-
skinned persons and with deep donor sites.
Delayed   healing  of   skin  donor   sites  may  be   costly   and  life
threatening,  especially  in patients with large  body-surface  area burns.
A donor  site dressing should maximize  the ability of  the wound  to heal
without increasing  the risk of local  infection,  systemic infection,  or
both.  Specifically,  the possibility  of a secondary  infection  may either
slow the healing  process  or ultimately  convert the donor  site to a  full-
thickness  wound.  A number  of materials,  ranging from gauze  to
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biological  agents, have been  investigated  for use as donor
sitedressings.
DONOR  SITE  HEALING  AND  THE  WOUND  ENVIRONMENT
Normal  wound  healing  is  a series  of  orchestrated  events  with
an  initiation   phase,  collagen  deposition  phase, keratinocyte  ingrowth
phase,   and  maturation  phase.   The process  is  dependent   on  oxygen
delivery  to  tissue,  pH  of tissue,  and  development  of  a  local  wound
environment conducive  to  the  cells  involved  in  repair.  Growth
factors  provided   exogenously   or   by  repairing   cells   have   been   the
focal  point  of  numerous  wound  healing  investigations,(4,49)1.
Brown  and  associates  [4]  investigated  epiderma1  growth  factor
(EGF)  in  association  with  skin  graft donor  site  healing.  This  work
showed that  EGF  decreased  the  time  to  healing  to  7-17  days  (mean:
10.9 days)  compared  with  9-21  days  (mean:  12.3  days)  for  control
donor  sites.
Madden   et   al   [42]   showed   that   exudates   from   wounds
occluded  with  a  hydrocolloid  dressing  promoted  keratinocyte
proliferation.
DONOR  SITE  HEALING  AND  BACTERIA
Where   healthy   tissue   exists   and   bacterial   populations   are
noninvasive,  wound  healing  proceeds  in  a  normal  fashion  .  In  these
cases,  bacterial  populations  may stimulate  the  inflammatory  response
that  initiates  wound healing.  Histologically  observed  invasion  of
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viable tissue  by pathogenic  organisms  distinguishes  invasive wound
sepsis  from  colonization [71].
Noninvasive  bacterial  populations  may  remain  over  the  surface
of   the  wound   without   impairing   healing   below  .  [59].  The   critical
factor   in  wound  healing appears  to  be  the  bacterial   population  in
the   wound,   as   opposed   to   the  population   over   the   surface   of  the
wound. Bacterial  populations  vary  over different  parts  of  the  body.
This   fact,   plus   concern   for   final   cosmetic  result,   may   influence
donor  site  selection  [23].  Preparation  of  the  donor  site  area  before
harvest,  as  well  as  careful  attention  to  hemostasis  and  clot  removal
from  the  bed  after   harvest,   may  be  important   for   the  control   of
microbial  populations  [57].  Depth  of  the  donor  area  not  only  affects
scar  formation,   but   may   also   have   a  role  in   the   incidence   of
infection  [23].   As   the   depth   of   the   wound   increases,   healing   is
slowed,   and   the   wound  becomes   more   susceptible   to   bacterial
contamination   as  the   time   to   healing   is   prolonged.   When
colonization  of  the  wound  occurs,  there  may  be  enhancement  of  the
initial   inflammatory   response   caused   by   skin   harvest.   If  this
inflammatory   response   persists,   the   ensuing   pathologic   finding   of
edema and  mediator-induced  necrosis  may  predispose  the  underlying
tissue  to  invasion.
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Early   after   harvest,   the   inflammatory   response   in   the
surrounding  tissue  may  mask  the  inflammatory  response  associated
with  bacterial  colonization.  Hunt  [31] showed  the  cascade  of
inflammatory  events  associated  with  normal  wound  healing;
however,  the  inflammatory  response  compounded  by  microorganisms
may   be   severe  and   lead   to   destruction   of   adjacent   tissue    [20].
Necrosis   of  tissue  assists   microbial   invasion  and  conversion  of  the
skin  graft  donor  site  to  a full  skin-thickness  injury  with  a  reported
incidence of infection  as  high  as  25%[21,30,42,70].
DONOR  SITE  DRESSINGS  AND  INFECTION
A   donor   site   dressing   should   maximize   the   ability   of   the
wound   to   heal  without   increasing   the   risk   of  local   or   systemic
infection.
 Donor   site  dressings   are   divided   into   several   categories:
OPEN,  SEMI-OPEN,  SEMI-OCCLUSIVE,  AND  OCCLUSIVE.
As   early   as   1962,   Winter  .   (Winter   CD  )[76]   showed   that
moist   wounds   healed   faster   than   wounds   left   to   dry   out.  This
observation  has  led  the  care  of skin  graft  donor  sites away  from  the
conventional   dry   gauze   dressings   toward   the   semi-occlusive   or
occlusive  dressings.  Although  these occlusive  dressings  provide  moist
environments   for   wound   healing,   there   has   been   concern   that
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occlusion  of  wounds  would  lead  to  increased  infection.(40)1.
However,  Hutchinson  and  McGuckin. (30) ,  in  a  review  of  29  donor
site  studies,  showed  an  infection  rate  of only  2.7% in  594  occluded
wounds   versus   an   infection   rate   of   6.4%  in   360   conventionally
dressed  wounds.
OCCLUSIVE TECHNIQUE
The early occlusive dressings consisted of a fine mesh gauze
covered with an impermeable dressing; these were abandoned in favor of
fine  mesh gauze alone because of the potencial for bacterial proliferation
and difficulty  in application to many areas, especially those other than
extremities  (42).
SEMI-OCCLUSIVE TECHNIQUE.
The group of clear films often referred to as SAM dressings
(synthetic adhesive moisture-vapor-permeable) was introduced for use on
skin graft donor sites . They are also bacteria and liquid impermeable and
so are considered semi-occlusive  (23).
While the results of numerous studies have shown these dressings
to promote more rapid and less painful healing, they tend to be labor-
intensive, especially in large donor sites, because of the potential for large
fluid colIections. This problem often requires placement of a drain
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beneath the dressing at the time of initial application or, altematively,
frequent aspiration or changing of the dressing (76,40).
OPEN TECHNIQUE
The open technique of leaving the wound uncovered is the least
expensive of any dressing, but is quite painful and is associated with
prolonged healing times (72).
SEMI-OPEN TECHNIQUE.
Prior studies of fine mesh gauzes impregnated with various
substances have described their ease of use and low cost, especially for
large donor sites (72). These dressings are semi-Open. There is egress of
fluid and bacteria through the fine mesh; as the dressing dries, fibrin from
the wound bed causes temporary bonding of the dressing to the wound
(30,70).
Split thickness skin graft donor sites have been treated with open or
closed  dressings.(59)  The open technique of donor dressing has been
long abandoned in  favour of the closed method since occlusive dressings
have shown better results with shorter healing time, superior quality of
the  regenerated  epithelium  and  more  patient  comfort.  It  has  also  shown
the added advantage of protecting the donor site from desiccation,
mechanical trauma and contamination.(59)  A more traditional method is
dressing the donor site with a fine mesh gauze beneath a closed absorbent
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dressing. The gauze may be dry but is usually impregnated with  bismuth,
scarlet red or petroleum jelly. Though the gauze initially provides a moist
environment it gradually becomes desiccated and an eschar forms which
acts as a mechanical barrier and impairs cellular migration. However
these dressings can also become permeable to bacteria if wound exudate
soaks through the entire thickness of the dressing. Furthermore movement
of the donor site dressing produces shearing forces that may cause pain,
dislodge the dressing and impair  the migration of  epithelial  cells.  At the
time of removal, the dressing is adherent and liable to damage the fragile
regrown epithelium(17,71).
Studies have shown that a moist environment promotes healing in a
partial thickness skin loss. The use of polyurethane film, a semi
permeable dressing maintains a moist environment allowing diffusion of
oxygen and water vapour while providing a barrier to the passage of
wound exudates. It has claimed to reduce the healing time and donor site
pain. However it has proved difficult to use as wound exudate collects
beneath the film and is liable to leak out( 17,71). Other experiments have
used silicon gel sheets, also a semi permeable dressing with similar
results.
BIOBRANE
Biobrane is a biocomposite of ultrathin semipermeable silicone
membrane bonded to a flexible knitted nylon fabric. The two layers are
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covalently bonded to porcine collagen peptides, which increase wound
adherence. The flexibility and stretch of Biobrane enable its application
to many different donor site areas; its high water vapor permeability
minimizes fluid collections, and the ability to see through it permits
ongoing evaluation of the wound. A limited number of studies comparing
Biobrane with more conventional donor site dressings have been showing
with mixed results.
DUODERM
Duoderm is  an oxygen-impermeable, hydrocolloid dressing, is
being used extensively for treatment of dermal ulcers, burns and minor
abrasions, and as a dressingfor skin graft donar sites. It is composed of an
outer layer of polyurethane foam that is impermeable to oxygen and
water and an inner layer of hydrocolloid polymer complex that is
occlusive and hydrophilic. Its oxygen impermeability has been shown to
promote the rate of epithelialization and collagen synthesis and to
decrease the pH of wound exudate, thus potentially reducing bacterial
counts (23,57,). Because the dressing does not adhere to open wounds, it
neither damages newly formed epithelium nor causes irritation or pain
during dressing changes. The results of studies comparing Duoderm  with
conventional fine mesh gauze have confirmed its potencial clinical
usefulness for skin graft donor sites with certain reservations (59,71,14).
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OMNIDERM
Omniderm is a polyurethane Film , which is transparent,
hydrophilic and highly permeable to water.
XEROFORM
A popular fine mesh gauze,  inexpensive,easy to use and associated
with a low infection rates. Results also confirm that reepithelialization of
donor sites covered with xeroform occurs in about ten days. However,
Xeroform  was  more  painful  as   a  dressing  than  Biobrane  or  Duoderm  .
Patients  complain most when the rolled  gauze bandage was removed on
the first postoperative day. Coagulum caused the Xeroform to stick to the
gauze and removal was quite painful.
OPSITE
It is a polyurethane dressing. These dressings will provide a seal,
thereby eliminating the risk of external infection as well as diminishing
pain.  In addition, these dressings have no pro-healing properties.
TEGADERM
Absorbent Clear Acrylic Dressing is a moisture-retentive,
absorbent dressing which combines the benefits of highly absorbent
dressings such as hydrocolloids, foams, alginates and hydrofibers with
the transparency of thin film dressings.
35
HYDROCOLLOIDS
These promote healing, leaving donor sites soft, pink, supple and
suitable for reharvesting, if necessary, within eight days (Doherty et al,
1986). They are simple to change and cause minimal disruption to new
epithelium. The patient experiences increased comfort and healing rates
and decreased pain. However, hydrocolloids can be costly and time
consuming and require many dressing changes due to leakage, which can
be offensive smelling and distressing for the patient.
CALCIUM ALGINATES
Attwood (1989) suggested these are inexpensive dressings, which
increase haemostasis, comfort, speed of healing and quality of the new
skin. They have been used quite widely for donor sites. They do have
problems with drying out and adhering to the wound surface.
SOFT SILICONE WOUND CONTACT DRESSING (MEPITEL)
This has not been used widely for donor sites, mainly due to cost,
which is significantly more than that for alginates or hydrocolloids.
However,  Mepitel  is  easier  to  remove  and  does  not  shed  fibres  into  the
wound. It has also been found to stop donor-site slippage (Wilkinson,
1997).
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FOAM DRESSINGS
There is a lack of research in the use of foam dressings to manage
donor sites but their absorbency and comfort suggests they might have a
place in this area.
Wilkinson (1997) supports this and suggests that foams have a low
adherence at the wound interface, can retain significant amounts of
exudate and can be cut to size.
HYDROFIBRE DRESSINGS
Successful use of these dressings (Aquacel) and those impregnated
with silver on donor sites have been reported (Barnea et al, 2004; Perlov
et al 2001).
TISSUE ENGINEERED WOUND MATRIX COVERAGE
The advantage of the use of Wound Matrix dressing is that the
dermis  lost  with  the  STSG  is  replaced  with  Wound  Matrix  as  it
incorporates.  The Tissue Engineered Wound Matrix also contains all the
active proteins and matrix components of dermis which can increase the
rate of re-epithelialization.  In addition, the use of a wound matrix results
in immediate wound closure thereby protecting the remaining dermis.
Recent experiments have shown that biological dressings create the
most physiological interface between the wound surface and the
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environment and permit the body’s reparative and immune system to
function most efficiently.
Experiments have been carried out using porcine xenografts,
amniotic membranes and collagen sheets. However both have shown poor
results. Porcine xenografts showed a large percentage of abnormal
healing due to sub epithelial incorporation and rejection and the amniotic
membrane dressings showed a delayed healing. (58). Collagen sheets
have been used as a donor site dressing which  comes close to being
called an ideal donor site dressing.
During the last decade, various new dressing materials developed,
like calcium alginate, hydro-colloid membranes and fine mesh gauze.
These have a disadvantage in that they become permeable to bacteria.
Biological dressings like collagen on the other hand, create the most
physiological interface between the wound surface and environment, and
are impermeable to bacteria(52).
Collagen dressings have other advantages over
* conventional  dressings  in  terms  of  ease  of   application  and
being natural non-immunogenic, non-pyrogenic, hypo-
allergenic, and pain-free.(41).
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ROLE OF HAEMOCOAGULASE WITH COLLAGEN SHEET IN
SSG DONOR SITE
In the recent years, patient census has increased four fold.
Rapid relief of pain is essential for early ambulation and discharge
of patients.
The objective was a cost effective measure to aid  pain relief and
good reepithelisation of the donor site.
INITIATIVE
Increasing patient census
Need for short hospital stay
Upgraded comfort
Reduction of donor site morbidity
HAEMOCOAGULASE
Haemocoagulase is isolated from bothrops atrox or botrops jarraca
(venoumous snake of South America). It is a C type lectin like protein.It
has Thrombin like action (rapid conversion of fibrinogen to fibrin) and
also has Thromboplastin like enzymatic activity(activates factor x) and
39
reduces capillary bleeding. It is available as a readily usable solution
(botroclot).
Collagen
Proteins are natural polymers and make up almost 15% of the
human body. The building blocks of all proteins are amino acids.
Collagen is the major protein of the extracellular matrix (ECM) and is the
most abundant protein found in mammals, comprising 25% of the total
protein and 70% to 80% of skin (dry weight). Collagen acts as a structural
scaffold in tissues. The central feature of all collagen molecules is their
stiff, triple-stranded helical structure.1 Types I, II, and III are the main
types of collagen found in connective tissue and constitute 90% of all
collagen in the body.
Previously, collagens were thought to function only as a structural
support; however, it is now evident that collagen and collagen-derived
fragments control many cellular functions, including cell shape and
differentiation,  migration,  and synthesis of a number of proteins.
Findings suggest that cell contact with precise extracellular matrix
molecules  influence cell behavior by regulating the quantity and quality
of matrix deposition.
Type I collagen is the most abundant structural component of the
dermal matrix; migrating keratinocytes likely interact with this protein.
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Collagenase (via formation of gelatin) may aid in dissociating
keratinocytes from collagen-rich matrix and thereby promote efficient
migration over the dermal and provisional matrices. Cellular functions are
regulated by the ECM. The information provided by ECM
macromolecules is processed and transduced into the cells by specialized
cell surface receptors.  Evidence demonstrates that the receptors play a
major function in contraction of wounds,  migration of epithelial cells,
collagen deposition,  and induction of matrix-degrading collagenase.
Although keratinocytes will adhere to denatured collagen (gelatin),
collagenase production is not turned on in response to this substrate.
Keratinocytes have been known to recognize and migrate on Type I
collagen substratum, resulting in enhanced collagenase production.
Collagen plays a key role in each phase of wound healing.
1.  Stops bleeding (Hovig et al 1968).
2. Helps in wound debridement by attracting Monocytes
(Postlewaithe and Kang 1976).
3.  Provides a matrix for tissue and vascular growth (Kleinman
et al 1981).
4. Attracts fibroblasts and helps in directed migration of cells
(Dunn and Ebendal, 1978).
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5.  Binds with Fibronectin, which promotes cell binding
(Kleinman et al, 1981).
6.  Supports growth (Morykwas et al 1989), differentiation and
migration (Emerman and Pitelka,1977) of keratinocytes.
7.  Helps in deposition of oriented and organised fibres
(Doillion et al, 1984) which increase the integrity of the
tissue.
The use of collagen dressing has been found to inhibit the action of
metalloproteinases.[ 74] Collagen is a biomaterial that encourages wound
healing through deposition and organization of freshly formed fibres and
granulation tissue in the wound bed thus creating a good environment for
wound healing. [50]
Collagen sheets, when applied to a wound, not only promote
angiogenesis, but also enhance body’s repair mechanisms.[ 52,41] While
acting as a mechanical support these reduce oedema and loss of fluids
from the wound site, along with facilitation of migration of fibroblasts
into the wound and enhancing the metabolic activity of the granulation
tissue.[ 52,48] Moreover, it is easy to apply and has the additional
advantage of stopping bleeding. (10)
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BIOLOGICAL ADVANTAGES OF COLLAGEN SHEET (28):
Collagen sheets are non-inflammatory
They facilitate migration of fibroblasts and microvascular cells
They help in the synthesis of neodermal collagen matrices
They have low antigenicity
They have minimal biodegradation
They are non-toxic
They help in minimising scarring
PHYSIOLOGICAL ADVANTAGES OF THE COLLAGEN
SHEETS :
They are impermeable to bacterial migration
They modulate fluid flux from the wound
They are elastic, soft, and supple, and therefore fit all contours
They have good tear strength
They have enough strength to be peeled off the wound.
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The most comprehensive care of donor site wounds was described
by Fowler and Dempsey (1998) who advised:
* Administer analgesia regularly
* Aid pain management by elevation and/or immobilisation of
the donor site area
* Observe and act upon signs of excess bleeding and pain from
infection that is  unrelieved by analgesia and pyrexia
* Reassure the patient regarding wound odour which may
cause embarrassment
* Only remove the dressing before the agreed date if it is
contaminated.
* Review the initial primary dressing choice and change to an
antimicrobial dressing if appropriate
* Ensure that the choice of dressing is practical and
appropriate for the patient
* Allow the primary wound contact layer to separate
spontaneously
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* Classify a donor site as healed only if the primary contact
layer is removed without pain leaving a dry, re-epithelialised
surface
* Ensure the patient has appropriate advice regarding
aftercare.
* Advice for patients about the donor site wound
* Patients need to be reassured that once the wound is healed it
is appropriate for  them to take over their own aftercare. The
donor site wound will appear dry, very  pink and possibly
itchy when it has recently healed.
* Patients will often be wary because it does not appear the
same as the rest of their  skin and will wonder whether this is
normal and whether the wound has healed.
* Patients should be given the following advice:
Although the wound may be itchy it is best not to scratch as the
new skin is  fragile and may be broken by scratching. Regular application
of emollients may help. The skin should be washed using a non-perfumed
soap and then patted dry rather than rubbed. (Fowler and Dempsey,
1998).
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MATERIALS AND METHODS
Conventional closed dressing with  Sterile Vaseline gauze and
Combination dressing with Haemocoagulase and sieved Collagen  Sheet
are applied to different subsets of patients  at the donor site following
harvesting of split skin graft.
Permission was obtained from ethical committee for this study
COMPARISION   of   Pain  at  the  donor  site,  Ambulation,
Reepithelisation of donor site wounds after 2 weeks was done.
INVESTIGATION
Blood haemoglobin
Blood sugar  and urea
Serum protein and creatinine
Blood group
Wound swab for culture and sensitivity
TREATMENT OPTIONS
1. CLOSED DRESSING with Vaseline impregnated gauze
application over the donorsite.
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2. OPEN DRESSING with Haemocoagulase and sieved Collagen
Sheet application over the donorsite
INCLUSION CRITERIAS
All patients are given vitamin and protein supplements and
appropriate antibiotics to minimize systemic factors interfering with
healing. Donor site raw areas  of  10x 10cm  to maximum of 25x 40 cm
was included for both groups
EXCLUSION CRITERIAS
Patients with Diabetes mellitus, Hypoproteinemia, Anemia were
excluded from study.
Donor sites after harvesting of thin split skin graft excluded from
study.
Large donor site raw areas were excluded from study in both
groups.
PERIOD OF STUDY
NOVEMBER 2009 TO JAN 2012’.
Study conducted on two groups of fifty patients. .
GROUP  I-control group had conventional closed dressing while
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GROUP II- the study group had haemocoagulase with collagen
sheet dressing. The study period was November 2009 – January 2012
Closed dressing -50 cases Haemocoagulase with  moist collagen sheet  -
50 cases.
PROCEDURE
GROUP I- The conventional closed dressing is by sterile vaseline
gauze to the donor site with bulky gamjee pad and bandage
GROUP II- 5 – 10 drops  of the haemocoagulase topical solution is
applied to the donor site.
Applied haemocoagulase solution is gently smeared over the donor
site.
Sterile moist collagen sheet is sieved and applied to the donor site
after checking haemostasis.
Sieving the moist collagen sheet helps in the drainage of the
exudate and air bubbles.
The collagen sheet on the donor site is allowed  to dry.
Patient is shifted to the post operative ward only after adequate
drying of  the collagen sheet. Extra care taken to prevent displacement of
collagen sheet during the shifting maneuvre.
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POST-OP ASSESSMENT
The  pain  experienced  at  the  donor  site  is  graded  as  per  the
universally followed pain scores  and recorded at 48 hours post op.
Time  of  starting  ambulation  of  the  patient  is  recorded  post
operatively and the day of significant pain free ambulation is noted in
both groups.
Wound reviewed daily in the combination dressing  and  closed
dressing group for soakage of dressing.
The separation of the collagen sheet from the donorsite and
loosening of the closed dressing   is observed for healing of donorsite  &
the re epithelisation of the wound is assessed.
ANALYSIS
Pain assessed as per pain    score at 48 hrs
Early ambulation  assesed
Daily review of the  wound
Re epithelisation of wound  assesed on day 15, 21
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NUMERICAL RATING SCALE (NRS)
FACES RATING SCALE (FRS)
The Numerical rating scale for pain is graded 0-10 and is useful for
educated patients.
No pain is grade 0 ,moderate pain is graded as 5 and worst possible
pain is grade 10.
The Wong baker face scale  is helpful for uneducated patients with
use of  pictorial representations of the painful facies.
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OBSERVATION & RESULTS
PAIN
 In our study, among the patients  the who had the conventional
donor site dressing with meshed Vaseline gauze had a median pain score
of  5  observed  in  23  patients.  Minimum  pain  score  in  this  group  was  3
noted in 2 patients. maximum pain score was 6 experienced in 4 patients.
Pain score of 4 was noted in 21 patients.
In comparision the combination dressing group with
haemocoagulase and collagen dressing had different results . the median
pain score was 2 experienced in 27 patients. Minimum pain score was 1
noted  in  6  patients.  Maximum pain  score  noted  in  the  collagen  dressing
group was 4 observed in 4 patients. The remaining 13 patients
experienced a pain score of 3. Pain was drastically reduced in the
collagen dressing patients.
AMBULATION
Since the pain score was high in the closed dressing subset of
patients, it limited their mobilization  and 22 patients were ambulant only
on postoperative day 3. Only 10 patients were ambulant on the 2nd post
operative day. The remaining 18 patients ambulated well only on the 4th
postoperative day.
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Due to the decreased pain in the collagen dressing for the donor
site  patients  ambulated  early   and  27  patients  were  ambulant  from  1  st
postoperative day.
Subsequently 21 patients were ambulant on 2nd post operative day.
The remaining 2 patients ambulated on the 3rd postoperative day.Early
ambulation was noted in the in patients with the collagen dressing
RE EPITHELISATION
Donor site reepithelisation was assessed in the closed dressing by
the  loosening   of  the  dressings  average  time  taken  for  the  donorsites  to
reepitheliase  was  20  -23  days.  Due  to  complications  of  donor  site
infection   the  donor  site  healing   extended  to  29  -31  days  in  about  6
patients.
Donor site reepithelisation was noted between 15-17 days in the
collagen dressing group. In 2 patients donor site healing  was delayed to
21-23 days  due to donor site infection which was treated by conservative
methods due to the ease of inspection of donor site and had the advantage
of early identification of donor site complications.  In 1 patient there was
displacement of collagen sheet  from the donorsite  and it was converted
to closed dressing and excluded from study. The healing time noted in
that  patient was 23 days.
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COST FACTOR ANALYSIS
The cost for the conventional closed dressings was Rs .150
inclusive of the  over padding needed in review period. The cost factor
for  application  25x40  cm moist  collagen  sheet  to  the  donor  site  was  Rs
450.
DONOR SITE COMPLICATIONS
Infection
Donor site infection was noted in 6 patients of the closed  dressing
group. It was  managed with conservative dressings  with framycetin.
donorsite dressings on  periodic review showing excessive soakage with
foul smell were opened end  wound swabs taken
Donor site infection noted in 2 patients in the collagen dressing
group, conservative e dressings done to treat with the infection in these
patients.
Collagen  Displacement-
1 patient in the study group had  shearing of collagen sheet when
applied to donor  site in the postoperative period. Wound was cleaned and
closed dressing applied and patient was excluded from the study.
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Donor site dressing problems
DRESSING SOAKAGE AND INFECTION
The donor site dressing soakage was more in the closed dressing
patients  and over padding done. This had the disadvantage of increased
bulk of the dressing. Malodour present due to dressing soakage was
promptly managed to rule out donor site infection. The increased bulk of
the dressing due to over padding and the seepage of exudates from
dressing to the garments produced a major discomfort in wearing the
garments in patients with closed dressing.  The combination dressing with
hemocoagulase and collagen dressing did not have disadvantage of
soakage of dressing nor bulky dressing. The patients had increased
comfort in wearing the garments which boosted the morale of the
patients and encouraged  early ambulation. Though the patients had
initially  apprehensions  due  to  the  exposed  raw  area  at  the  donor  site,
patients were counseled and in the post operative period direct
visualization of the healing donor sites lessened their anxiety. The
reduced pain, comfort of dressing and advantage to wear the garments
early made patients who were subjected to multiple grafting procedures
and treated with both methods of dressing opt for the combination
dressing in subsequent procedures.
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OBSERVATIONS
COLLAGEN
DRESSING
CLOSED
DRESSING
PAIN SCORE 2 5
AMBULANT ON 1st POD 3rd POD
REEPITHELISATION 15-17 DAYS 20-23 DAYS
COST FACTOR RELATIVELY
EXPENSIVE
LESS EXPENSIVE
COLLAGEN DRESSING
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CLOSED DRESSING
COLLAGEN DRESSING
POST OPERATIVE DAY
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CLOSED DRESSING
Intensity of pain was drastically reduced in the  combination
treatment  group treated with hemocoagulase and collagen sheet. This
facilitated early ambulation from  the very next day.
Complete epithelisation was found in all cases. Eventhough the
procedure was  more expensive, it will be cost effective in the longrun as
it helps in higher  turnover of patients with better acceptability. Shearing
of collagen sheet on the posterior thigh donor sites is common and may
lead to significant donor site morbidity.
Patients who were subjected to multiple grafting  procedures felt
collagen  dressing was  better and comfortable.
POST OPERATIVE DAY
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DISCUSSION
Split-thickness skin grafting (STSG) is a frequently used
reconstructive technique but is associated with variations in practice.
Rakel et al (1998) in the review of the literature found a transparent film
to be the best dressing for the care of STSG donor sites. This review of 33
studies found that  transparent film was associated with one of the fastest
healing rates, a smooth epithelialized surface, a low infection rate, the
least amount of pain and minimal cost.
Numerous controlled studies in the last 50 years have established
that moist wound healing is the best evidence based practice. Dried
wound tissue is more prone to complications such as infection, scarring,
pain and prolonged healing. The goal of treating skin graft donor sites is
to promote healing while minimizing the risk of introducing new
complications and pain to an already traumatized patient.
Essentially, the wound was left open to scab, which is
contradictory to the best evidence-based practice of today, that of moist
wound healing. In recent years, much has been published highlighting the
benefits of moisture-retentive dressings in treating donor sites.
Moisture-retentive dressings that have been used include
hydrocolloids, foams, and transparent thin film dressings, alone or in
combination with absorbent materials such as alginates, hydrofibers or
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gauze. While hydrocolloids and foams provide the needed absorbency,
they must be removed whenever wound inspection is required, increasing
treatment cost and the risk of traumatizing the wound. Thin film dressings
allow for wound visualization, but usually fail to contain the  drainage for
more than 24 hours, even when used secondary to other absorbent
dressings (which also negates the benefit of transparency).Tegaderm™,
Absorbent Clear Acrylic Dressing is a moisture-retentive, absorbent
dressing which combines the benefits of highly absorbent dressings such
as hydrocolloids, foams, alginates and hydrofibers with the transparency
of thin film dressings. Recent published work indicates that this dressing
provides excellent results with skin donor sites2,3.
As   early   as   1962,   Winter   [15]   showed  that  moist   wounds
healed  faster  than  wounds  left  to  dry  out. This  observation  has  led
the  care  of  skin  graft  donor  sites  away  from  the  conventional   dry
gauze   dressings   toward  the   semi-occlusive   or   occlusive   dressings.
Although  these occlusive  dressings  provide  moist  environments  for
wound  healing,   there   has   been   concern   that   occlusion   of  wounds
would  lead  to  increased  infection  [16-181.  How- ever,  Hutchinson
and  McGuckin  [19], in  a  review  of  29 donor  site  studies,  showed  an
infection   rate   of  only   2.7%  in   594   occluded   wounds   versus   an
infection  rate  of  6.4% in  360 conventionally  dressed  wounds  (Figure
1).  In  a recent  study  on  donor  site wound  healing,  30  burn patients
with   skin   graft   donor   sites   were   randomized   to  receive   either   an
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occlusive (DUODERM) or conventional gauze dressing  on their  wounds
[2]. Wounds  in  both  groups  were  colonized with  bacteria;  however,
only  conventionally  dressed wounds  became  infected (Table  I).
Bacteria   were   pre-  sent   intraoperatively   in   9   of   14   (64%)
hydrocolloid-  treated   sites   and   in   5  of   16  (31%)   conventionally
treated sites.
Moist wound healing is not a new idea and providers continue to
strive to find the optimal treatment that provides this ideal, moist
environment. George Winter is often referenced as a pioneer among
wound-care practitioners because of his work in the early 1960s that
proved wounds re-epithelialize quicker in a moist environment (Winter,
1963). It is indeed the epithelialization process on which we focus when
treating the skin graft donor site. Historically, the most popular way of
treating skin graft donor sites is the dry open technique using either
scarlet  red  or  petrolatum bismuth  dressings.  A heat  lamp or  air  blowing
device is then placed over the area to dry out the donor site and form a
scab. This process is commonly perceived as a painful treatment so
investigators sought a pain free dressing that allowed for absorption of
the excessive exudate as well as hemostasis. There are even reports of
placing wax paper over the area thereby protecting the nerve endings
from the pain in an attempt to heal the superficial wound (Weeter, 1952).
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Utilization of a moisture vapor permeable transparent dressing
yielded freedom from pain, early healing, and less bulky dressings,
however, post-operative leakage from the site required frequent dressing
changes on the fragile tissue (James & Watson, 1975). The aim became
marrying the advantages of painless and moist wound healing with the
concept of absorption. Epinephrine applied to the fresh donor site was
proposed as a solution to excessive sanguinous exudate, but there was
still dressing slippage leaving the donor site exposed (Pontén &
Nordgaard, 1976). In addition, the concern of infection with occlusive
dressings was raised, but Birdsell, Hein, and Lindsay (1979) found no
infections in the 100 patients studied with occlusive dressings. Salisbury,
Bevin, Dingeldein, and Grisham (1979) investigated polyurethane foam
but found that the histologic examination of the pig’s skin showed no
evidence that the foam made a difference in healing time despite the
dressing’s painless removal. The idea of hemostasis was achieved
utilizing an alginate dressing, which also provided the absorption
component yet the dressing still required changing prior to complete
healing, resulting in a painful event (Groves & Lawrence, 1986).
Attwood (1989) continued the use of alginate and demonstrated a
decrease in healing time compared to paraffin gauze dressings.
In the 1990s, the quest continued with the introduction of Biobrane
as a cover over the donor site, yet its cost and rate of infection were too
much to accept when Xeroform (a bismuth petrolatum-impregnated
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nonstick antimicrobial gauze) continued to be cheap and easy despite the
advantage of reduced pain with Biobrane (Feldman, Rogers, & Karpinski,
1991). The hydrocolloid emerged as a winner because it had a high rate
of absorption, showed fewer infections, and had more rapid healing with
acceptable leakage (Smith, Thomson, Bolton, & Hutchinson,1993). By
1995, Griswold et al. (1995) evaluated a new dressing that was made
from type I bovine collagen. Of no surprise, this dressing indeed healed
faster than  Xeroform and was less painful, however, the collagen had to
be inspected and the dressing changed on days 3, 5, and 7 Patients with
collagen dressings are found to have only minimal to moderate pain in the
entire post operative period and during the first dressing. In these patients
analgesic requirement is reduced and early mobilisation can be done.
Thus the major advantage of using collagen as a donor site dressing is
decreased pain.
The collagen sheet once adherent to the wound has low friction
between the wound surface and dressing and this has made it suitable for
awkwardly sited donor sites. (Gupta RL, Jain RK, Kumar M, et al).
Also once applied it does not require a bulky dressing which would
hamper mobilisation, or require a change of dressing as there is no
soakage of the dressing due to wound exudate.
The burn literature continues to examine more donor-site dressings
than any other discipline and Duinslaeger, Verbeken, Vanhalle, and
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Vanderkelen (1997) evaluated cultured allogeneic keratinocyte sheets.
These sheets accelerated healing compared with  transparent dressings
but were quite expensive.
A  systematic  review  in  1998  answered  the  question  of  cost  but
started with the various options for dressing selection on the donor site.
A review performed by Rakel et al. (1998) found that in the last 40
years the transparent dressing still reigns because of its association with
faster healing rates, smooth epithelialized surface, low infection rates,
less pain, and minimal cost.
 Despite the increasing array of products available and this review,
the most commonly used dressing was the calcium alginate even though
it is not rated high in dressing performance (Lyall & Sinclair, 2000). The
most important item from the survey was patient comfort. The gold
standard by which other dressings are now being measured moved away
from the transparent dressing to the calcium alginate but the alginate fell
short in comparison with the silicone-coated polyamide net (Mepitel;
O’Donoghue, O’Sullivan, O’Shaughnessy, & O’Connor, 2000).
Although Mepitel is virtually nonstick and can be left in place for
days at a time, it requires secondary dressings to absorb moisture.
Chitosan is a derivative of shrimp exoskeleton and has the ability to
rapidly clot blood. The chitosan is being impregnated into gauze
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dressings and used in the field during times of war. This mixture is also
hypoallergenic and has natural anti-bacterial properties. With such
promise, it was only a matter of time that this dressing was evaluated on
the donorsite. Stone, Wright, Clarke, Powell, and Devaraj (2000) were
impressed with the re-epithelialization rates and regeneration of nerves
within the vascular dermis, but the use of chitosan was limited because of
availability. The foray into these often-expensive and limited dressings
prompted some to ask whether the dry open technique was indeed better.
The limitation of this technique due to pain, already detailed, led to a
modification.
The donor site was still left open but under moist conditions
utilizing the application of Moist Exposed Burn Ointment. Although the
full action of the ointment is unknown, Atiyeh, Ghanimeh, Kaddoura,
Ioannovich, Al-Amm (2001) determined that even in their limited
evaluation, there was some promise because of the cosmetic outcome. At
this point, it seems there can be no more new and original ideas in the
arena of donor-site care but a novel topical application must be explored
despite its obvious limitations. Egg membrane as a biological dressing
was evaluated by Yang, Chuang, and Tsay (2003). The dressing indeed
provided pain relief, protection, and healing, and was low cost, yet the
size of the dressing was limited and the feasibility was narrow. Despite
continued examination of foam, alginate, collagen, and even cellulose,
there were not many discoveries but rather the continued confirmation
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that the alginate and transparent cover were supreme. Then, a new
absorbent transparent dressing hit the wound-care market and was
immediately evaluated by Terrill, Goth, and Bailey (2007) on donor-site
wounds. Terrill et al. found the dressing to be cost comparative and easy
to apply. The donor-site scars with this dressing were less red and itchy,
flatter, and softer. The best attribute of the dressing, of course, was pain-
free healing. The 3M Tegaderm Absorbent Clear Acrylic Dressing is a
moisture-retentive dressing that is absorbent yet transparent. The product
is designed to be changed every 3–5 days per manufacturer guidelines yet
donor sites on average take up to 14 days to heal completely. Even with
the benefit of pain-free dressings, the patient still has to endure two to
three dressing changes until healing has been achieved.
In our study significant pain reduction, early ambulation,
comfortable dressing, similar to the study of Collagen Dressing in The
Management of Donor Site of Split Thickness Skin Grafts (P Halankar*,
D Cunha-Gomes**, C Chaudhari*) good reepithelisation, and early
discharge of the patients with signs of good healing was noted in the
collagen dressing. P Halankar*, D Cunha-Gomes**, C Chaudhari* , at
Bombay Hospital and Medical Research Centre, studied a group of 30
patients were included in this study with 21 males and 9 females ranging
from age 18 to 72 years. All patients required  split thickness skin grafts
of approximately 100-250 cm2 in area to provide cover for various
indications . In the group all patients tolerated the collagen dressing well
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and there was no allergic reaction. In the early postoperative period on
assessment  of  donor  site  pain  to  touch  and  pressure,  2  patients  in  the
group had no pain, 23 rated the pain as minimal while 7 patients assessed
the pain as moderate and tolerable. There was no complaint of severe
pain and none of the patients required additional analgesics for donor site
pain. Once the patients were mobilized by the third postoperative day
they were assessed again for pain while walking. In the patient group 21
patients assessed the pain as minimal, 7 assessed the pain as moderate
and 2 as severe. The 2 patients who had severe pain on walking also had
severe  pain  on  touch  and  pressure  and  required  additional  analgesics  to
relieve them of the donor site pain. All other patients had no analgesic
requirement for the donor site.
 In 2 patients soakage of wound exudate was seen on the fifth and
eighth post operative day respectively. These were the two patients in
whom there was significant donor site pain. In both patients the donor site
dressing was foul smelling and the wound was covered with purulent
discharge with degradation of the collagen sheet. The infection was
limited to the donor site with no evidence of cellulitis of the surrounding
skin or fever. The infected sites were redressed with framycetin
impregnated paraffin gauze. In both patients the wounds were redressed
after forty-eight hours by which time pain had subsided. On the
fourteenth post operative day the donor site dressings were soaked in
saline and easily removed with no pain in 5 patients, while 18 and 7
patients had minimal and moderate pain respectively. None of them
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complained of severe pain. In the group 24 patients showed 100%
reepithelialisation, 4 showed between 90-100%, while the two with
infected donor sites had < 90% reepithelialisation. In the group 1 patient
had a haematoma beneath the collagen dressing but there was complete
re-epithelialisation beneath the haematoma. On late follow up of 26
patients, 2 showed hypertrophic scarring of the donor site.
In our study the median pain score was 2 in the  collagen dressing
compared to the increased pain score of 5 in the conventional closed
dressing group. Patients were ambulant from postoperative day 1 with
the collagen dressing, while patients with the bulky closed dressing were
ambulant from the third postoperative day.
In our study cost factor analysis increased  expenditure towards
collagen dressing, but the above advantages help in rapid turnover of
patients with minimal donor site morbidity which is the need of the hour
in recent treatment protocols in management of rawareas. The advantage
of direct review of the donorsite wound in the collagen group helps in
early identification of problems and also manage the wounds properly
and salvage them from becoming full thickness wounds which will
increase donor site morbidity.
Skin graft donor sites in burn patients warrant intense treatment
and optimal wound-management techniques. An ideal dressing method
prevents dehydration and infection while facilitating wound healing.
Dressings should be easy to apply and require minimal care.
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CONCLUSION
Haemocoagulase with Collagen sheet application for donor site
have the following advantages.
? Less pain over the donor site compared to the conventional closed
dressing with Vaseline gauze.
? Early ambulation due to reduced pain after the application of
collagen sheet to the donor site.
? Reepithelisation complete for most patients and time of
reepithelisation is similar to the standard expensive dressings for
the donor site.
? Inspection  of  the  donor  site  wound  can  be  done  easily  and
complications can be recognized early.
? A comfortable Dressing due to the decreased bulk of dressing and
ease to wear the garments over the dressing.
? Less complications and better outcome compared to the
conventional closed dressing.
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CLOSED DRESSING
HAEMOCOAGULASE WITH COLLAGEN SHEET DRESSING
HAEMOCOAGULASE APPLICATION
SIEVED COLLAGEN SHEET
COLLAGEN SHEET APPLIED TO DONOR SITE
DONOR SITE HEALING – COMBINATION DRESSING 1
DONOR SITE HEALING – COMBINATION DRESSING 2
DONOR SITE HEALING – COMBINATION DRESSING 3
HAEMOCOAGULASE  WITH COLLAGEN SHEET FOR
ANTERIOR AND LATERAL THIGH DONOR SITE
REEPITHELISATION OF DONOR SITE
DONOR SITE COMPLICATIONS
DISPLACEMENT OF COLLAGEN SHEET
NAME AGE SEX IP NO CLOSED DONOR SIZE(cm) PAIN AMBULATION
REVIEW
REMARKS
REEPITHELISAT
ION SOAKAGE INFECTION
DATE OF
SURGERY
DRESSING SITE POD
SUDHARSAN 28 MALE 29230 YES L(T) 25X30 4 3 20 MINIMAL NIL 14/12/09
MOHAN 39 MALE 29236 YES R(T) 25x30 4 3 20 MODERATE NIL 17/12/O9
SAROJA 28 FEMALE 29302 YES L(T) 25X30 6 4 FOUL SMELLING 29 SEVERE STAPH.AUREUS 3/12/2009
MEENAKSHI 29 FEMALE 29315 YES L(T) 15X25 5 2 21 MODERATE NIL 5/12/2009
RAJA 30 MALE 29381 YES L(T) 20X25 5 4 20 MODERATE NIL 17/12/09
PADMAVATHY 32 FEMALE 29350 YES L(T) 25X30 3 3 20 MODERATE NIL 24/12/09
DEVI 36 FEMALE 29354 YES L(T) 25X30 5 3 20 MODERATE NIL 12/12/2009
NATARAJAN 39 MALE 29366 YES L(T) 20x30 4 4 21 MODERATE NIL 16/12/2009
SUGUNA 26 FEMALE 29386 YES R(T) 25x30 5 3 20 MODERATE NIL 12/12/2009
PANNERSELVAM 39 MALE 29402 YES R(T) 20x30 5 3 21 MODERATE NIL 3/1/2010
RAJAKUMARI 27 FEMALE 10171 YES R(L) 10x15 4 2 20 MINIMAL NIL 7/1/2010
ROSELINE 39 FEMALE 10196 YES L(T) 15X25 4 2 20 MINIMAL NIL 21/01/2010
THIRUMAL 40 MALE 10251 YES L(T) 25X30 5 4 FOUL SMELLING 30 MODERATE STAPH.AUREUS 3/2/2010
VENKATESAN 42 MALE 10457 YES L(T) 25X30 4 4 21 MODERATE NIL 22/02/2010
SRIDHAR 27 MALE 11036 YES L(T) 25X30 5 3 21 MODERATE NIL 7/3/2010
SARAVANAN 28 MALE 12781 YES L(T) 25X30 6 4 FOUL SMELLING 30 SEVERE STAPH.AUREUS 15/03/2010
SIVAGAMI 32 FEMALE 12861 YES R(T) 25X30 4 4 20 MODERATE NIL 21/03/2010
SURESH 29 MALE 13741 YES R(T) 25X30 4 3 20 MODERATE NIL 3/4/2010
SARALA 36 FEMALE 14501 YES R(T) 20X25 5 3 20 MINIMAL NIL 14/04/2010
SOUMYA 17 FEMALE 14556 YES L(T) 15x25 5 3 20 MODERATE NIL 18/04/2010
MANI 41 MALE 15771 YES L(T) 20x30 5 2 21 MODERATE NIL 4/5/2010
SHANTHI 28 FEMALE 15892 YES L(T) 20x30 5 3 20 MODERATE NIL 11/5/2010
LAKSHMI 24 FEMALE 16402 YES L(T) 20x30 5 2 20 MODERATE NIL 27/05/2010
DHANALAKSHMI 26 FEMALE 17819 YES L(T) 20x30 4 3 20 MODERATE NIL 6/6/2010
VISWANATHAN 39 MALE 18721 YES R(T) 25X30 5 4 20 MODERATE NIL 10/6/2010
MANIKANDAN 25 MALE 20231 YES L(T) 25X30 3 4 21 MODERATE NIL 17/06/2010
PUSHPARAJ 43 MALE 20239 YES L(T) 25X30 6 4 FOUL SMELLING 31 MODERATE STAPH.AUREUS 15/07/2010
MARIAPPAN 39 MALE 22214 YES R(T) 15x25 4 2 20 MINIMAL NIL 12/8/2010
RAMANAN 37 MALE 22291 YES R(T) 15x25 4 3 20 MODERATE NIL 21/09/2010
MAHALINGAM 35 MALE 22317 YES L(L) 10x15 4 3 20 MINIMAL NIL 2/10/2010
SUSEELA 32 FEMALE 24331 YES R(T) 25X30 5 3 21 MODERATE NIL 17/10/2010
BALAN 30 MALE 25430 YES R(T) 25X30 5 4 FOUL SMELLING 30 MODERATE STAPH.AUREUS 3/11/2010
ASHOK 24 MALE 10871 YES R(T) 20x30 5 3 20 MODERATE NIL 28/11/2010
KUMAR 26 MALE 11782 YES L(T) 20x30 4 4 20 MODERATE NIL 24/12/2010
ARUMUGAM 40 MALE 12001 YES L(T) 20x30 4 3 20 MODERATE NIL 5/1/2011
RAGHU 36 MALE 12585 YES L(T) 20x30 6 4 FOUL SMELLING 30 SEVERE STAPH.AUREUS 22/01/2011
AKILESHWARI 25 FEMALE 13145 YES L(T) 15x25 5 3 20 MODERATE NIL 3/2/2011
GOVINDARAJ 51 MALE 14392 YES L(T) 15x25 5 2 21 MODERATE NIL 9/2/2011
VELUSAMY 47 MALE 14953 YES R(T) 25X30 5 4 20 MODERATE NIL 3/3/2011
NARAYANAN 32 MALE 15745 YES R(T) 25X30 4 4 20 MODERATE NIL 15/03/2011
POWN 34 FEMALE 16709 YES L(T) 20x30 4 4 20 MODERATE NIL 19/03/2011
GOWRI 26 FEMALE 17123 YES R(T) 20x30 4 4 20 MODERATE NIL 3/4/2011
VISHNU 24 MALE 17789 YES R(T) 25X30 4 4 20 MODERATE NIL 6/5/2011
PADMINI 45 FEMALE 19254 YES R(T) 15x25 5 2 21 MODERATE NIL 3/6/2011
SENTHIL 25 MALE 20258 YES R(T) 15x25 5 3 20 MODERATE NIL 17/7/2011
KUMARAN 29 MALE 22354 YES R(T) 15x25 5 4 FOUL SMELLING 29 SEVERE STAPH.AUREUS 21/10/2011
LAKSHMI 22 FEMALE 22514 YES L(T) 15x25 4 2 20 MODERATE NIL 27/10/2011
MURUGAN 35 MALE 10971 YES L(T) 20x30 5 3 21 MODERATE NIL 12/11/2011
SHAKILA 21 FEMALE 1009 YES L(T) 20x30 4 3 20 MODERATE NIL 3/1/2012
MEHRUNISHA 24 FEMALE 1257 YES L(T) 15x25 4 2 20 MINIMAL NIL 21/01/2012
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VINITHA 16 FEMALE 29230 14/12/2009 L(T) 15X30 YES YES 2 1 15 NIL
SANDHYA 9 FEMALE 29452 18/12/2009 L(T) 25X30 YES YES 2 1 15 NIL
ANNAMALAI 35 MALE 29232 12/12/2009 L(T) 25X30 YES YES 2 1 17 NIL
HIYAKATHULLAH 30 MALE 29515 18/12/2009 L(T) 25X30 YES YES 3 2 15 NIL
SASIKALA 20 FEMALE 11052 27/12/2009 R(T) 25X30 YES YES 2 2 17 NIL
PRIYA 25 FEMALE 11534 6/12/2009 L(T) 25X30 YES YES 4 1 16 NIL
THIRUPURA SUNDARI 65 FEMALE 11896 22/12/2009 L(T) 10X15 YES YES 1 1 17 NIL
LOGANATHAN 29 MALE 12758 3/1/2010 L(L) 15X30 YES YES 2 2 15 NIL
SURESH 25 MALE 13564 12/1/2010 R(T) 15X30 YES YES 2 1 15 NIL
LAKSHMI 32 FEMALE 14011 27/01/2010 R(T) 15X30 YES YES 3 1 17 NIL
DHATCHAYANI 30 FEMALE 14545 6/2/2010 R(T) 25X30 YES YES 2 2 15 NIL
RATHI 23 FEMALE 15149 24/02/2010 R(T) 15X20 YES YES 2 1 15 NIL
SELVI 26 FEMALE 16188 3/3/2010 L(T) 20X30 YES YES 2 1 15 NIL
VANITHA 35 FEMALE 18433 23/03/2010 L(T) 15X20 YES YES 1 1 15 NIL
ANITHA 28 FEMALE 19010 2/4/2010 L(T) 15X20 YES YES 1 2 16 NIL
MANOHAR 49 MALE 19581 17/04/2010 L(T) 25X30 YES YES 3 1 17 NIL
PRABHA 17 MALE 20039 21/04/2010 L(T) 25X30 YES YES 2 1 17 NIL
PARI 40 MALE 21051 4/5/2010 R(T) 25X30 YES YES 4 3 INFECTION+ 20 staph.aureus
GEMINI 25 MALE 22007 15/05/2010 R(T) 25X30 YES YES 3 2 16 NIL
KEERTHIKA 19 FEMALE 22678 19/05/2010 L(T) 20X30 YES YES 3 1 15 NIL
DHANALAKSHMI 55 FEMALE 22912 12/6/2010 L(T) 20X30 YES YES 2 2 16 NIL
BHUVANESHWARI 24 FEMALE 23439 17/06/2010 L(T) 20X30 YES YES 2 1 16 NIL
VIDHYA 23 FEMALE 23931 4/7/2010 L(T) 20X30 YES YES 3 1 16 NIL
NANDHINI 15 FEMALE 23974 17/07/2010 R(L) 25X30 YES YES 3 2 16 NIL
MATHIALAGAN 42 MALE 24117 27/07/2010 L(T) 25X30 YES YES 2 2 17 NIL
JANCY 29 FEMALE 24616 16/08/2010 L(T) 25X30 YES YES 2 1 15 NIL
BALU 25 MALE 24938 23/08/2010 R(T) 15X20 YES YES 1 1 15 NIL
SATHYA 17 FEMALE 12065 11/9/2010 R(T) 15X20 YES YES 2 2 15 NIL
KANNAN 19 MALE 12679 23/09/2010 R(T) 15X20 YES YES 2 1 15 NIL
ILAYARAJA 25 MALE 13119 13/10/2010 R(T) 15X30 YES YES 3 2 17 NIL
THILOTHAMAL 35 FEMALE 13474 11/11/2010 R(T) 15X30 YES YES 2 2 16 NIL
SUMITHRA 26 FEMALE 13675 7/12/2010 L(T) 15X30 YES YES 2 1 17 NIL
KALAI SELVI 24 FEMALE 15153 7/1/2011 L(T) 15X20 YES YES 3 1 15 NIL
VASANTH 24 MALE 16117 3/2/2011 L(T) 15X20 YES YES 2 2 15 NIL
SRIKANTH 25 MALE 16297 27/02/2011 L(T) 15X20 YES YES 2 1 16 NIL
YUVARAJ 21 MALE 16537 7/3/2011 L(T) 20X30 YES YES 2 1 16 NIL
ALEX 30 MALE 17103 15/03/2011 L(T) 20X30 YES YES 2 2 17 NIL
SRINIVASAN 34 MALE 17539 12/4/2011 R(T) 20X30 YES YES 2 1 16 NIL
MUTHU 30 ,ALE 17714 14/05/2011 R(T) 20X30 YES YES 3 2 15 NIL
RAMACHANDRAN 18 MALE 17912 3/6/2011 R(T) 25X30 YES YES 4 3 INFECTION + 23 staph.aureus
SINGARAJ 45 MALE 18215 6/6/2011 R(T) 25X30 YES YES 1 2 15 NIL
MARIMUTHU 45 MALE 18456 16/07/2011 L(T) 25X30 YES YES 3 1 16 NIL
KUMARI 23 FEMALE 18509 28/07/2011 L(T) 15X20 YES YES 3 1 16 NIL
SAKTHIVEL 30 MALE 19004 20/11/2011 L(T) 15X20 YES YES 2 2 16 NIL
SARAVANA KUMAR 26 MALE 20031 24/11/2011 L(T) 15X20 YES YES 2 1 16 NIL
NOORULA KHAN 40 MALE 21237 2/12/2011 R(T) 15X20 YES YES 2 2 17 NIL
SASI KUMAR 24 MALE 22549 7/12/2011 R(T) 20X30 YES YES 4 1 16 NIL
GUNASUNDARI 36 FEMALE 23112 23/12/2011 R(T) 25X30 YES YES 3 2 16 NIL
BASKAR 35 MALE 10975 O2/01/2012 L(T) 15X20 YES YES 1 2 16 NIL
ARUL 30 MALE 1151 6/1/2012 L(T) 15X20 YES YES 2 2 16 NIL
